规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
Animal study | The impact of achieving pancreatic rest through the oral administration of the CCK-1 receptor antagonist Loxiglumide, along with the effects of pancreas stimulation by endogenous CCK release induced by the protease inhibitor camostat, was studied in the recovery of pancreatic secretory function and the biochemical and histological changes in the pancreas following acute hemorrhagic pancreatitis. Administering Loxiglumide at a dose of 50 mg/kg body weight effectively inhibits pancreatic exocrine secretion for over 12 hours. Consequently, administering Loxiglumide every 12 hours could potentially block the effects of endogenously released CCK, thereby providing pancreatic rest[1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.17mL 0.43mL 0.22mL |
10.84mL 2.17mL 1.08mL |
21.67mL 4.33mL 2.17mL |
CAS号 | 107097-80-3 |
分子式 | C21H30Cl2N2O5 |
分子量 | 461.38 |
SMILES Code | O=C(O)CCC(NC(C1=CC=C(Cl)C(Cl)=C1)=O)C(N(CCCOC)CCCCC)=O |
MDL No. | MFCD00866772 |
别名 | CR-1505 |
运输 | 蓝冰 |
InChI Key | QNQZBKQEIFTHFZ-UHFFFAOYSA-N |
Pubchem ID | 60182 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|